Composition
- Active ingredients
- CLORAZEPATE DIPOTASSIUM 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**
Strengths and forms
The FDA lists each strength of a product separately; these pages share one label.
- CLORAZEPATE DIPOTASSIUM 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA017105-008 · Discontinued
- CLORAZEPATE DIPOTASSIUM 3.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · TabletNDA017105-006 · Discontinued
- CLORAZEPATE DIPOTASSIUM 7.5MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · CapsuleThis page
- CLORAZEPATE DIPOTASSIUM 7.5MG · TabletNDA017105-007 · Prescription
- CLORAZEPATE DIPOTASSIUM 15MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · CapsuleNDA017105-003 · Discontinued
- CLORAZEPATE DIPOTASSIUM 3.75MG **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons** · CapsuleNDA017105-001 · Discontinued
Official product information
Drugs@FDA lists the approved labels, letters and reviews for application NDA017105.
At a glance
- Brand name
- Tranxene
- Active substance
- clorazepate dipotassium
- Route
- Oral
- Dosage form
- Capsule
- Applicant
- Ajenat Pharms
- Status
- Discontinued
- FDA approval
- 23 Jun 1972
- Application
- NDA017105-002